Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Therapeutic Innovation & Regulatory Science|September 21, 2018
Adaptive Clinical Trials: Overview of Phase III Designs and ChallengesJeff Maca, Vladimir Dragalin, Paul GalloClinical Trials (London, England)|March 27, 2010
Barriers and opportunities for implementation of adaptive designs in pharmaceutical product developmentJudith Quinlan, Brenda Gaydos, Jeff Maca, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 21, 2004
Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patientsMaurizio Salvadori, Herwig Holzer, Angelo de Mattos, et al.Pharmaceutical Statistics|July 30, 2013
Multiplicity: discussion points from the Statisticians in the Pharmaceutical Industry multiplicity expert groupAlan Phillips, Chrissie Fletcher, Gary Atkinson, et al.Therapeutic Innovation & Regulatory Science|September 22, 2018
Addressing Challenges and Opportunities of "Less Well-Understood" Adaptive DesignsWeili He, Paul Gallo, Eva Miller, et al.Therapeutic Innovation & Regulatory Science|September 22, 2018
DIA's Adaptive Design Scientific Working Group (ADSWG): Best Practices Case Studies for "Less Well-understood" Adaptive DesignsEva Miller, Paul Gallo, Weili He, et al.JAMA Neurology|March 25, 2024
Early Use of Erenumab vs Nonspecific Oral Migraine Preventives: The APPRAISE Randomized Clinical TrialPatricia Pozo-Rosich, David Dolezil, Koen Paemeleire, et al.Pageof 1